CVIA Journal

Cardiovascular Innovations and Applications

Press Release Volume 2 Number 2

New Issue of Cardiovascular Innovations and Applications Journal (Volume 2 Issue 2) Published with Special China Focus issue.

Beijing, 16 June, 2017: The new journal Cardiovascular Innovations and Applications (CVIA) has just published the second issue of Volume 2, with a Special China Focus issue.

The CVIA China Focus issue has been Guest Edited by Professor Changsheng Ma, Capital Medical University and National Center for Cardiovascular Clinical Research, Beijing, China and brings together contributions from leading cardiologists in the United States and China together with several commentaries by C. Richard Conti, the Editor-in-Chief of CVIA.

Featured papers in this issue are:

Precision Medicine in Cardiovascular Diseases

by Yan Liu and Jie Du (DOI 10.15212/CVIA.2017.0003)

Since President Obama announced the Precision Medicine Initiative in his State of the Union Address in January 2015, more and more attention has been paid to precision medicine. However, clinicians have already used it to treat conditions such as cancer. Many cardiovascular diseases have a familial presentation, and genetic variants are associated with the prevention, diagnosis, and treatment of cardiovascular diseases, which are the basis for providing precise care to patients with cardiovascular diseases. Large-scale cohorts and multiomics are critical components of precision medicine. In this paper, the authors summarize the application of precision medicine to cardiovascular diseases based on cohort and omic studies, and hope to elicit discussion about future health care. The authors conclude ‘Precision medicine has been recognized as a new era in health care. With multiomic analysis, data collected from analysis of genetic variants, biomarker detection, and phenotype assessment can be integrated and used to improve strategies for preventing, diagnosing, and treating diseases in individual patients. Precision medicine both offers promise and presents challenges to the future care of individuals with cardiovascular disease.’

The Role of Echocardiography in Hypertrophic Cardiomyopathy

by Jing Ping Sun, Xing Sheng Yang, and Shaochun Wang  (DOI 10.15212/CVIA.2016.0061)

Hypertrophic cardiomyopathy (HCM) is a common genetic cardiovascular disease and appears in all ethnic groups. HCM is diagnosed on the basis of left ventricular hypertrophy. Echocardiography is a key technique in the diagnosis of HCM, the prognosis of patients with HCM, the management strategy for HCM, and the follow-up of patients with HCM. This paper briefly describes and discusses the practical use of established echocardiography techniques and the current and emerging echocardiographic methods that can help physicians in the correct diagnostic and pathophysiological assessment of patients with HCM. The authors conclude that Echocardiography is an invaluable tool in the screening and diagnosis of HCM. It is also the first noninvasive imaging method for risk stratification, treatment selection and follow-up of patients. Two-dimensional and Doppler echocardiography are useful for evaluation of LV diastolic and systolic function, which is important for clinical practice. Two-dimensional strain is a simple, rapid, and reproducible method for early detection of early abnormalities in HCM patients with normal LV systolic function. The diagnosis of HCM is still challenging, and diagnosis can only be 100% reliable when a gene mutation is identified. No single echocardiographic parameter is ideal, and history and clinical examination play a vital role.’

Great Wall International Congress of Cardiology (GWICC) and Relationship to the American

College of Cardiology (ACC) and the New Journal, CVIA

by C. Richard Conti   (DOI 10.15212/CVIA.2016.0036).

In this Commentary paper, the Editor-in-Chief, Dr Conti traces his involvement with the GWICC to his first presentation of a scientific paper at the GWICC in 2003, following an invitation by Professor Hu Dayi. Dr Conti writes: ‘’During that time, I lectured at both Beijing and Shanghai and developed a close relationship to Prof. Hu…We discussed the possibility of a joint American College of Cardiology, Great Wall International Congress of Cardiology, symposium in Beijing, China at the next GWICC meeting. After discussion with the ACC leadership, this joint meeting came to fruition, and every year since, in October, the ACC president leads a delegation to Beijing, China to participate and discuss cardiovascular issues common to the Chinese and Americans. The ACC faculty is chosen by the ACC president and the topics are variable but generally relate to primary and secondary prevention of cardiac disease.’’ Dr Conti goes on to discuss the foundation of the CVIA journal and his vision for its future: ‘’Recently, because of my relationship to Professor Hu, I have been asked to serve as Editor in chief of Cardiovascular Innovations and Applications (CVIA) journal. This is a great honor for me, since the journal is the official journal of the GWICC. My goal is to develop a first rate English language peer reviewed cardiovascular journal over the next several years. Obviously we must start slowly, but eventually, with the help of the editorial board (including Professor Ma, Associate Editor of the journal), the journal will be published monthly, the readership and impact factor will be increased, and submission of material from all parts of the world, not just China will be encouraged.’’

CVIA is available on the IngentaConnect platform and at http://cvia-journal.org/. Submissions may be made using ScholarOne Manuscripts (https://mc04.manuscriptcentral.com/cvia-journal). There are no author submission or article processing fees.

Updated: June 22, 2017 — 10:26 am
Cardiovascular Innovations and Applications is indexed in the OCLC, Primo Central (Ex Libris), Sherpa Romeo and NISC (National Information Services Corporation) Databases
EX-Lib-90x50 OCLC-90x50 sherpaNISC logo
CVIA Journal © 2015